Certain aspects of toxicity of an amicarbalide formulation to ponies.
D000429:Alcohol Oxidoreductases; D000578:Amidines / Q000008:administration & dosage / Q000633:toxicity; D000813:Anilides / Q000008:administration & dosage / Q000633:toxicity*; D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000633:toxicity*; D001219:Aspartate Aminotransferases / Q000097:blood; D001404:Babesiosis / Q000188:drug therapy; D001663:Bilirubin / Q000097:blood; D001806:Blood Urea Nitrogen; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006736:Horses; D007273:Injections, Intramuscular; D007668:Kidney / Q000473:pathology; D007958:Leukocyte Count; D008099:Liver / Q000473:pathology; D008297:Male; D009132:Muscles / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D013012:Sorbitol; D013448:Sulfobromophthalein / Q000097:blood; D014508:Urea / Q000008:administration & dosage / Q000633:toxicity*
D000578:Amidines; D000813:Anilides; D000981:Antiprotozoal Agents; D006454:Hemoglobins; D013448:Sulfobromophthalein; D013012:Sorbitol; D014508:Urea; D000429:Alcohol Oxidoreductases; D001219:Aspartate Aminotransferases; D001663:Bilirubin